Career Updates

Jul 6, 2026 1:48 pm

Yeoun Jin Kim

Yeoun Jin Kim Appointed Executive Director at AstraZeneca

Yeoun Jin Kim, Executive Director of Biomarker Science and Technologies at AstraZeneca, shared a post on LinkedIn:

“I am excited to share that I have stepped into a new role as Executive Director.

While continuing to lead the Translational Proteomics group within Biomarker Science and Technologies (BST) at AstraZeneca, this new role will focus on shaping the future of Precision Medicine and exploring new opportunities beyond what is possible today.

I am grateful to my team, colleagues, and leadership for their trust, collaboration, and shared vision of the transformative potential of clinical proteomics.

Thank you to everyone who has been part of this journey. I look forward to the opportunities ahead.”

Other Articles About AstraZeneca On OncoDaily.

Stay Informed

Subscribe to OncoDaily Newsletter

Don't miss the latest news in oncology: stay up to date with daily picks from OncoDaily.

Subscribe

• Career Updates

AstraZeneca Biomarker Science & Technologies biomarkers Biotechnology BST cancer Cancer research Clinical Proteomics drug development executive leadership Healthcare Innovation life sciences molecular diagnostics OncoDaily Oncology oncology research personalized medicine Precision Medicine Proteomics Translational Proteomics translational research translational science Yeoun Jin Kim